Research programme: pain therapies - Microbia
Alternative Names: Dual action analgesic; Pain therapies research programme - MicrobiaLatest Information Update: 03 Aug 2006
At a glance
- Originator Microbia
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 03 Aug 2006 No development reported - Preclinical for Pain in USA (unspecified route)
- 07 Jul 2004 Preclinical trials in Pain in USA (unspecified route)